Related references
Note: Only part of the references are listed.Epoxyeicosatrienoic Acid Analogs and Vascular Function
V. Sudhahar et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Targeting Epoxides for Organ Damage in Hypertension
John D. Imig
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
Jan M. Williams et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats
Agnieszka Walkowska et al.
JOURNAL OF HYPERTENSION (2010)
Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice
Hantz C. Hercule et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
Jun-Yan Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice
Luděk Červenka et al.
JOURNAL OF HYPERTENSION (2009)
Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats
Michaela Erbanova et al.
JOURNAL OF HYPERTENSION (2009)
The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension
Yi Zhang et al.
JOURNAL OF HYPERTENSION (2009)
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease
Pietro Minuz et al.
HYPERTENSION (2008)
Afferent arteriolar dilation to 11,12-EET analogs involves PP2A activity and Ca2+-Activated K+ channels
John D. Imig et al.
MICROCIRCULATION (2008)
Vascular cytochrome P450 enzymes: Physiology and pathophysiology
Ingrid Fleming
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Orally bioavailable potent soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways
Shilin Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension
Harpreet Singh et al.
HYPERTENSION (2007)
Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats
Hui Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors
William B. Campbell et al.
HYPERTENSION (2007)
Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis
Jan M. Williams et al.
HYPERTENSION (2007)
The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats
Vera Certikova Chabova et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2007)
Effects of 20-HETE on Na+ transport and Na+-K+-ATPase activity in the thick ascending loop of Henle
Ming Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension
J. H. Capdevila et al.
KIDNEY INTERNATIONAL (2007)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
O Jung et al.
HYPERTENSION (2005)
Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways
Y Wei et al.
JOURNAL OF GENERAL PHYSIOLOGY (2004)
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2
M Spiecker et al.
CIRCULATION (2004)
Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases
XY Zhao et al.
HYPERTENSION (2003)
Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat
HC Hercule et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arterioles
D Wang et al.
KIDNEY INTERNATIONAL (2003)
Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats
F Zhang et al.
HYPERTENSION (2001)
Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid
JD Imig et al.
JOURNAL OF HYPERTENSION (2001)
Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin
JD Imig et al.
JOURNAL OF VASCULAR RESEARCH (2001)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats
CT Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport
R Quigley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole
K Kohagura et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2000)
Share Paper
